BALYASNY ASSET MANAGEMENT L.P. - ASTRIA THERAPEUTICS INC ownership

ASTRIA THERAPEUTICS INC's ticker is and the CUSIP is 04635X102. A total of 77 filers reported holding ASTRIA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of ASTRIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$462,062
-13.0%
50,776
+34.6%
0.00%0.0%
Q1 2024$531,148
-91.8%
37,737
-92.2%
0.00%
-93.8%
Q1 2023$6,462,989485,9390.02%
Other shareholders
ASTRIA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Altium Capital Management LP 1,355,372$20,181,48910.26%
Fairmount Funds Management LLC 1,901,397$28,311,8014.49%
Tri Locum Partners LP 651,330$9,698,0003.92%
Vivo Capital, LLC 1,681,199$25,0332.88%
Ghost Tree Capital, LLC 450,000$6,701,0002.86%
Affinity Asset Advisors, LLC 472,482$7,035,2572.76%
Ikarian Capital, LLC 675,176$10,053,3702.42%
Cormorant Asset Management, LP 1,650,000$24,5691.64%
Logos Global Management LP 864,960$12,879,2541.51%
SPHERA FUNDS MANAGEMENT LTD. 469,340$6,988,4731.50%
View complete list of ASTRIA THERAPEUTICS INC shareholders